Triglav Investments, D.o.o. »

Revolution Medicines shares owned by Triglav Investments, D.o.o.

Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by Triglav Investments, D.o.o. from 13F filings

Historical chart of Triglav Investments, D.o.o. investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by Triglav Investments, D.o.o. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by Triglav Investments, D.o.o.

Quarter filed Position value Share count Share price at filing
2026-06-30 $394k 2.1k 187.28

More positions owned by Triglav Investments, D.o.o.

Nvidia Corporation Common (NVDA)
Amazon.com Common (AMZN)
Microsoft Corporation Common (MSFT)
Apple Common (AAPL)
Alphabet Common (GOOGL)
Micron Technology Common (MU)
Broadcom Common (AVGO)
Eli Lilly And Company Common (LLY)
Jpmorgan Chase & Co. Common (JPM)
Advanced Micro Devices Common (AMD)
Goldman Sachs Group Inc/the Common (GS)
Meta Platforms Common (META)
Taiwan Semiconductor Manufacturing Common (TSM)
Lam Research Corporation Common (LRCX)
Alphabet Common (GOOG)

View all positions for Triglav Investments, D.o.o.

Top funds holding Revolution Medicines

BlackRock
Farallon Capital Management
FMR
Baker Bros. Advisors
Jupiter Topco
Darwin Global Management
Henderson Group
Vanguard Capital Management
Vanguard Portfolio Management
Nextech Invest
Paradigm Biocapital Advisors
UBS Group
State Street Corporation
Geode Capital Management
Wellington Management Company

View all funds holding Revolution Medicines